News

Metformin is typically taken with meals to reduce gastrointestinal side effects. However, recent data indicate that administering metformin before meals can improve glycaemic control and that this is linked ...

New research suggests that hypoglycaemia during sleep may have been underestimated by up to 30% in previous studies. The results were obtained by using continuous glucose monitoring (CGM) in addition to cust...

More than half of all men with diabetes have impaired sexual health, most commonly due to erectile dysfunction. In women with diabetes, sexual dysfunction is less prevalent, but still occurs. In a joint sess...

Challenges for people with t1d doing sports and access to diabetes tech in lower income countries were some of the focus topics on the final day of ATTD2024. Julia Mader sums up her impressions from the conf...

We focus on Chantal Mathieu’s update on CGM derived data in weekly insulins in our newsflash from #ATTD2024 Day 3. Another standout moment for us was the EUDF joint session. It explored how artificial ...

Day 2 of ATTD 2024 came with updates on hypoglycaemia with Prof Pratik Choudhary and the unveiling of new monitoring guidance for presymptomatic type 1 diabetes with Co-Ch...

Highlights from Day1 of the 17th Conference on Advanced Technologies and Treatments for Diabetes with Prof Melanie Davies and Renza Scibilia.

Determining which treatment is suited best for specific patient groups can be a complex challenge. A recent study proposes a simple roadmap to guide clinicians through the interpretation of subgroup meta-ana...

‘Epidemiologic trends and disparities in diabetes risk factors among LGBTQ+ populations’ was the title of a presentation at the 59th Annual Meeting of the EASD and it highlighted the need for mor...

Undiagnosed diabetes is a burgeoning problem. A recent study tested people for prediabetes and diabetes when they were admitted to A&E and preliminary findings were presented at the 59th Annual Meeting o...

People with type 1 and type 2 diabetes may need emergency treatment when hyperglycaemia gets out of hand. The American Diabetes Association (ADA), EASD and others have just updated their guidance on the mana...

Health disparities in diabetes care arise from many causes. A new study in a recent issue of Diabetologia uses the ACCORD trial to explore the influence of racial, ethnic and economic factors in achieving di...

One of the tasks that can be performed by artificial intelligence (AI) is diagnosing diabetic retinopathy from a retinal photograph with a performance that rivals that of a human grader. A new review in Diab...

There is increasing interest in the role of the microbiome in many areas of medicine, including diabetes, in the hope of discovering novel therapeutic applications. A symposium at the 59th Annual Meeting of ...

With its comprehensively revised, reorganised and updated course on SGLT-2 inhibitors, launched today, EASD e-Learning signals a new phase in the learning platform’s development.

A new study reported in Diabetologia looks at the risk factors for developing diabetes among a cohort of pregnant women after giving birth. The research shows that decline in beta cell function is ranked as ...

Recent research suggests that there is much more to obesity than elevated body mass index. The latest findings on the role of liver fat and metabolically healthy obesity were under discussion at the 59th Ann...

Factors other than hyperglycaemia influence complications for both mother and baby in a pregnancy affected by type 1 diabetes. New metabolomic findings from the CONCEPTT trial, reported in Diabetologia, shed...

The benefits of SGLT-2 inhibitors for people with type 2 diabetes and chronic kidney disease (CKD) have been amply demonstrated in recent years. So is it time to prescribe them to all those who have both con...

A number of drugs that mimic or enhance incretin agonism are now being used for glucose lowering in diabetes. They have proven cardiovascular safety and may even reduce cardiovascular complications. A new re...

The latest research into hypoglycaemia was under discussion at the 59th Annual Meeting of the EASD. The ‘To hell with the hypo’ session covered topics ranging from a tool to predict nocturnal hyp...